AXIAL BIOTHERAPEUTICS

Serial Number 87425837
Registration 6463769
700

Registration Progress

Application Filed
Apr 26, 2017
Under Examination
May 22, 2018
Approved for Publication
Mar 27, 2018
Published for Opposition
Mar 27, 2018
Registered
Aug 24, 2021

Trademark Image

AXIAL BIOTHERAPEUTICS

Basic Information

Serial Number
87425837
Registration Number
6463769
Filing Date
April 26, 2017
Registration Date
August 24, 2021
Published for Opposition
March 27, 2018
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 24, 2021
Registration
Registered
Classes
001 005

Rights Holder

AXIAL THERAPEUTICS, INC.

03
Address
Suite 6990
400 Trade Center Dr.
WOBURN, MA 01801

Ownership History

Axial Biotherapeutics, Inc.

Original Applicant
03
Boston, MA

Axial Biotherapeutics, Inc.

Owner at Publication
03
Waltham, MA

AXIAL THERAPEUTICS, INC.

New Owner After Publication #1
03
WOBURN, MA

AXIAL THERAPEUTICS, INC.

Original Registrant
03
WOBURN, MA

Legal Representation

Attorney
Ian W. Gillies

USPTO Deadlines

Next Deadline
615 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210824)
Due Date
August 24, 2027
Grace Period Ends
February 24, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Aug 24, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 23, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jul 22, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jul 9, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 9, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 8, 2021 ALIE A ASSIGNED TO LIE Loading...
May 21, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 15, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 15, 2021 GNRT O NON-FINAL ACTION E-MAILED Loading...
Apr 15, 2021 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Mar 25, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 24, 2021 IUAF S USE AMENDMENT FILED Loading...
Mar 24, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 24, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 2, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 1, 2020 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 17, 2020 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 1, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 17, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 16, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 14, 2020 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 14, 2020 EXT4 S SOU EXTENSION 4 FILED Loading...
May 14, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 20, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 18, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 18, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 18, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 1, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 27, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 27, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 27, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 21, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 19, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 19, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 19, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 22, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 27, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 27, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 7, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 20, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 26, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 25, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 25, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 28, 2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 28, 2017 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 28, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 24, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
May 4, 2017 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
May 3, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 29, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Microbes for use in the manufacture of probiotic supplements; probiotic bacteria and probiotic bacterial cultures; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Chemical, biochemical and biotechnological preparations used in industry and science, namely, antibodies and fragments of antibodies for use in the manufacture of pharmaceutical preparations; Chemical products, namely, small molecules for the treatment of gastrointestinal diseases, microbiome related conditions, central nervous system diseases and disorders, or any disease or disorder associated with leaky gut
First Use Anywhere: Mar 12, 2021
First Use in Commerce: Mar 12, 2021
Class 005
Probiotic or microbe-targeted pharmaceutical preparations and substances for the treatment of gastrointestinal diseases, microbiome related conditions, central nervous system diseases and disorders, or any disease or disorder associated with leaky gut
First Use Anywhere: Mar 12, 2021
First Use in Commerce: Mar 12, 2021

Additional Information

Design Mark
The mark consists of the wording "AXIAL BIOTHERAPEUTICS" with an elongated oval shape as one of the lines in the "X", and a round shape with intersecting lines to the left of the wording.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
AXIAL BIO THERAPEUTICS

Classification

International Classes
001 005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTHERAPEUTICS"